Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

Senator Christopher Cabaldon (D-Yolo) announced Senate District Three’s 2025 Woman of the Year — Carol Whichard, who was ...

SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, today announced that it has dosed the first patient in the ...

Researchers at Kumamoto University have successfully executed a practical trial of a new genome-editing technique that allows ...

Spliceosome structures have been investigated extensively in the past decade, but most of the studies have been restricted to ...

QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price ...

Hikvision showcased its e volving AV ecosystem at ISLE 2025, which took place at the Shenzhen World Exhibition & Convention ...

CommScope announced the launch of its Propel XFrame™ solution as the latest addition to the Propel™ portfolio of ...

A viral video on TikTok claims that Kenyan president William Ruto has appointed opposition leader Raila Odinga as the new prime cabinet secretary.

The self-fusing silicone tape market share analysis is poised for significant expansion, expected to surpass USD 30,870.8 ...

Plants survive cold by adjusting at cellular level. Scientists discovered that the PORCUPINE protein helps plants adapt to ...